Publication Cover
Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
Revue canadienne des soins respiratoires et critiques et de la médecine du sommeil
Volume 7, 2023 - Issue 3
172
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Prevalence and outcomes of interstitial lung abnormalities in a Canadian lung cancer screening trial

, , , , , & show all
Pages 140-143 | Received 14 Dec 2022, Accepted 06 May 2023, Published online: 24 May 2023

References

  • Hatabu H, Hunninghake GM, Richeldi L, et al. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society. Lancet Respir Med. 2020;8(7):726–737. doi:10.1016/S2213-2600(20)30168-5.
  • Hewitt RJ, Bartlett EC, Ganatra R, et al. Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease. Thorax. 2022;77(11):1149–1151. doi:10.1136/thorax-2022-219068.
  • Steele MP, Peljto AL, Mathai SK, et al. Incidence and Progression of Fibrotic Lung Disease in an At-Risk Cohort. Am J Respir Crit Care Med. 2023;207(5):587–593. doi:10.1164/rccm.202206-1075OC.
  • Tomassetti S, Poletti V, Ravaglia C, et al. Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives. Eur Respir Rev. 2022;31(164):210206. doi:10.1183/16000617.0206-2021.
  • Hunninghake GM, Goldin JG, Kadoch MA, et al. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative. Chest. 2022;161(2):470–482. doi:10.1016/j.chest.2021.06.035.
  • Tremblay A, Taghizadeh N, Huang J, et al. A Randomized Controlled Study of Integrated Smoking Cessation in a Lung Cancer Screening Program. J Thorac Oncol. 2019;14(9):1528–1537. doi:10.1016/j.jtho.2019.04.024.
  • Tremblay A, Taghizadeh N, MacGregor JH, et al. Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study. J Am Coll Radiol. 2019;16(10):1425–1432. doi:10.1016/j.jacr.2019.03.006.
  • Tammemägi MC, Ruparel M, Tremblay A, et al. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study. Lancet Oncol. 2022;23(1):138–148. doi:10.1016/S1470-2045(21)00590-8.
  • Tremblay A, Ezer N, Burrowes P, et al. Development and application of an electronic synoptic report for reporting and management of low-dose computed tomography lung cancer screening examination. BMC Med Imaging. 2022;22(1):111. doi:10.1186/s12880-022-00837-y.
  • Putman RK, Hatabu H, Araki T, et al. Association Between Interstitial Lung Abnormalities and All-Cause Mortality. Jama. 2016;315(7):672–681. doi:10.1001/jama.2016.0518.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.